Ensuring drug safety : where do we go from here? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005.

Similar Items

• Drug user fees : enhancing patient access and drug safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session on examining enhancing patient access and drug safety relating to prescription drug user fees, including S. 484, March 14, 2007.
  Published: (2008)
• Restoring FDA's ability to keep America's families safe : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, second session on examining the U.S. Food and Drug Administration, focusing on its ability to ensure the safety of food and the drug supply in the United States, April 24, 2008.
  Published: (2009)
• Building a 21st century FDA : proposals to improve drug safety and innovation : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session on examining proposals to improve drug safety and innovation, and S. 3807, to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, November 16, 2006.
  Published: (2007)
• FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet meets standards for safety and efficacy, March 1, 2005.
  Published: (2005)
• Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010
  Published: (2012)